Caitlin Turner

Title: Innovations of Caitlin Turner in Genetic Engineering

Introduction

Caitlin Turner is an accomplished inventor based in Durham, NC (US). She has made significant contributions to the field of genetic engineering, particularly in the development of engineered meganucleases. With a total of three patents to her name, her work is paving the way for advancements in genetic modification and therapeutic applications.

Latest Patents

Caitlin Turner's latest patents focus on polynucleotides encoding engineered meganucleases that have specificity for recognition sequences in the dystrophin gene. These engineered meganucleases are designed to bind and cleave recognition sequences within the dystrophin gene. The patents also encompass methods for using these engineered meganucleases to create genetically modified cells. Furthermore, the disclosures include pharmaceutical compositions that comprise engineered meganuclease proteins or polynucleotides encoding these proteins. These compositions are intended for the modification of the dystrophin gene in subjects, offering potential treatment options for Duchenne Muscular Dystrophy.

Career Highlights

Caitlin Turner is currently employed at Precision Biosciences, Inc., where she continues to innovate in the field of genetic engineering. Her work is characterized by a commitment to advancing therapeutic solutions for genetic disorders.

Collaborations

Caitlin collaborates with notable colleagues such as Gary Owens and Janel Lape, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Caitlin Turner's contributions to genetic engineering through her patents and work at Precision Biosciences, Inc. highlight her role as a leading inventor in the field. Her innovative approaches to addressing genetic disorders are paving the way for future advancements in medical treatments.